# Rivastigmine Transdermal System

NDC: 51991-899
Generic name: Rivastigmine
Labeler / Manufacturer: Breckenridge Pharmaceutical, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: PATCH, EXTENDED RELEASE
Routes: TRANSDERMAL
Marketing started: 20191219

FDA application: ANDA209063

## Active ingredients

- RIVASTIGMINE: 13.3 mg/24h

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51991-899"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51991-899
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b201fe68-b5e5-4a6f-8cf1-069543f03e76